A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment

Clinical trial NCT07343960 · RECRUITING

Trial details

NCT number: NCT07343960
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate Hepatic Impairment

Start date: 2026-01-06
Primary completion: 2026-11-11
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.